BOSTON, Oct. 6, 2021 /PRNewswire/ -- Haemonetics
Corporation (NYSE: HAE) announced that the Company intends to
publish second quarter fiscal year 2022 financial results at 6:00
am EST on Tuesday, November 9, 2021.
The Company will hold a conference call with investors and analysts
to discuss results and answer questions at 8:00 am EST on November
9, 2021.
The call can be accessed with the following information:
U.S. / Canada toll free (877)
848-8880; International (716) 335-9512
Conference ID required for access: 3529538
A live webcast of the call can be accessed on Haemonetics'
investor relations website. Webcast Link:
https://edge.media-server.com/m6/p/qyrbnnofhttps://edge.media-server.com/mmc/p/apntfy73
A replay of the conference call and webcast will be available
for one year beginning on November 9,
2021 at 11:00 a.m. EST using
the conference call webcast link provided in this press
release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated
to providing a suite of innovative hematology products and
solutions for customers, to help them improve patient care and
reduce the cost of healthcare. Our technology addresses important
medical markets: blood and plasma component collection, the
surgical suite, and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com.
|
Investor
Contact:
Olga Guyette,
Director-Investor Relations
(781)
356-9763
olga.guyette@haemonetics.com
|
|
Media
Contact:
Josh Gitelson,
Director-Global Communications
(781)
356-9776
josh.gitelson@haemonetics.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2022-results-november-9-2021-301394550.html
SOURCE Haemonetics Corporation